Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
January 03 2006 - 4:18PM
PR Newswire (US)
SAN DIEGO, Jan. 3 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will be presenting at the JPMorgan Healthcare
Conference on Monday, January 9, 2006 at 9:00 AM PT in San
Francisco. Ginger L. Graham, Chief Executive Officer of Amylin
Pharmaceuticals, will be providing a corporate overview. The live
presentation and breakout session will be webcast, and recordings
will be made available following the event. The webcasts and
recordings will be accessible through Amylin's corporate website,
located at http://www.amylin.com/. To access the live webcasts,
please log on to Amylin's site approximately fifteen minutes prior
to the presentation to register and download any necessary audio
software. Amylin Pharmaceuticals is a biopharmaceutical company
committed to improving lives through the discovery, development and
commercialization of innovative medicines. DATASOURCE: Amylin
Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive Director,
Investor Relations of Amylin Pharmaceuticals, Inc.,
+1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024